Home › Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis › Minnesota › Minneapolis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis clinical trials in Minneapolis, MN
3 studies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
RecruitingPhase 4
- University of Minnesota, Minneapolis
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RecruitingPhase 1/2
- Nkarta Investigational Site, Minneapolis
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecruitingPhase 1
- University of Minnesota Medical School, Minneapolis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trials in other cities
Other studies in Minneapolis
- Non-Small Cell Lung Cancer27 studies
- Breast Cancer27 studies
- Ovarian Cancer24 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Acute Myeloid Leukemia20 studies
- Lung Cancer20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer18 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.